Ozempic, a diabetes medication by Novo Nordisk, has gained popularity for its weight loss effects, sparking debate.
The FDA said Eli Lilly’s weight-loss drugs were no longer in shortage on Oct. 2, preventing pharmacies from making cheaper ...
"These medications can potentially impact vaginal health in several unexpected ways," Bone told the outlet. "Firstly, the ...
Block Novo Holdings' USD16.5B Catalent acquisition: Consumer Groups Urge FTC over antitrust concerns
The deal could constrain options for competitors such as Amgen, Pfizer, Roche, and AstraZeneca , who are reportedly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback